Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Novartis AG

NVSNYSE
Healthcare
Drug Manufacturers - General
$153.44
$-0.81(-0.53%)
U.S. Market opens in 0h 43m

Novartis AG (NVS) Stock Overview

Explore Novartis AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap296.7B
P/E Ratio21.08
EPS (TTM)$7.15
ROE0.33%
Fundamental Analysis

AI Price Forecasts

1 Month$153.66
3 Months$191.85
1 Year Target$159.73

NVS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Novartis AG (NVS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 39.24, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $159.73.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 21.08 and a market capitalization of 296.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.50%
5-Day Change
-2.06%
1-Month Change
-5.90%
3-Month Change
15.77%
6-Month Change
23.65%
Year-to-Date (YTD) Change
10.78%
1-Year Change
40.67%
3-Year Change
98.73%
5-Year Change
90.16%
All-Time (Max) Change
875.72%

Contact Information

41 61 324 1111
Lichtstrasse 35, Basel, NaN, 4056

Company Facts

758,830 Employees
IPO DateNov 7, 1996
CountryCH
Actively Trading

Frequently Asked Questions